Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

285
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
285

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association between D-dimer difference and risk of postoperative venous thromboembolism in endometrial cancer: a retrospective cohort study.

Thrombosis journal·2026
Same author

An engineered aryl sulfotransferase for the biosynthesis of glycosaminoglycans.

International journal of biological macromolecules·2026
Same author

Mitophagy in inflammatory bowel disease: regulatory mechanisms and therapeutic potential.

Frontiers in cell and developmental biology·2026
Same author

Integrative transcriptomic and single-cell analysis reveals metabolic reprogramming and hexosamine biosynthesis-mediated tumor microenvironment remodeling in prostate cancer.

Discover oncology·2026
Same author

Engineering Chondroitinase-Free Baculovirus-Insect Cell Expression System for Efficient Synthesis of Chondroitin Sulphates.

Microbial biotechnology·2026
Same author

A fluorescence-activated droplet sorting assay for ultra-high-throughput screening of PET hydrolases based on a pH indicator.

RSC chemical biology·2026
Same journal

Identification of FMR1 as a novel cancer prognostic and immunotherapy biomarker through renal cancer experimental validation and pan-cancer analysis.

Discover oncology·2026
Same journal

A novel prognostic zinc finger gene model for hepatocellular carcinoma via machine learning.

Discover oncology·2026
Same journal

High RSPO3 protein expression serves as an independent poor prognostic factor and promotes malignant progression in breast cancer.

Discover oncology·2026
Same journal

Identification of exosome-related genes signature based on bioinformatics and machine learning for prognostic prediction in colorectal cancer.

Discover oncology·2026
Same journal

Tumor location and morphological MRI features in relation to combined 1p/22q deletion in meningioma.

Discover oncology·2026
Same journal

Tumor-induced immune escape mechanisms and translational immunotherapeutic strategies.

Discover oncology·2026
See all related articles

Related Experiment Video

Updated: May 23, 2025

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
09:49

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Published on: December 28, 2021

3.3K

XGBoost model for predicting erectile dysfunction risk after radical prostatectomy: development and validation using

Hesong Jiang1, Lu Ji1, Leilei Zhu2

  • 1Department of Urology, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Huaian City, 223300, Jiangsu Province, China.

Discover Oncology
|May 19, 2025
PubMed
Summary
This summary is machine-generated.

A machine learning model using XGBoost accurately predicts erectile dysfunction (ED) after prostate surgery. This tool aids personalized patient management by identifying key risk factors for ED.

Keywords:
Erectile dysfunction (ED)Machine learningRadical prostatectomyRisk predictionXGBoost model

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.0K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K

Related Experiment Videos

Last Updated: May 23, 2025

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
09:49

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Published on: December 28, 2021

3.3K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.0K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K

Area of Science:

  • Urology
  • Oncology
  • Data Science

Background:

  • Erectile dysfunction (ED) is a common, quality-of-life impacting complication after radical prostatectomy.
  • Traditional methods for predicting ED risk are limited in capturing complex, nonlinear factors.

Purpose of the Study:

  • To develop and validate a machine learning (ML) model for improved ED risk stratification post-radical prostatectomy.
  • To enhance personalized patient management strategies for ED.

Main Methods:

  • Analysis of 1,147 prostate cancer patients, with 285 (24.85%) developing ED.
  • Utilized ML models (XGBoost, Random Forest, SVM, k-NN) trained on identified risk factors.
  • Key predictors included age, smoking, Gleason score, prostate volume, T-stage, surgical approach, operative time, and PCT levels.

Main Results:

  • XGBoost demonstrated superior predictive accuracy (AUC 0.960 in validation) and clinical utility.
  • Calibration and decision curve analyses confirmed model performance and benefit.
  • SHAP analysis identified key risk contributors for individualized assessment.

Conclusions:

  • The XGBoost model offers robust predictive performance and clinical applicability for ED risk assessment.
  • Provides a valuable tool for personalized postoperative management of ED after radical prostatectomy.